{"text": ["Why", "Eli", "Lilly", "Shares", "Traded", "Higher", "Today"], "created_at": "2021-11-02 20:24:38"}
{"text": ["Metacrine", "Posts", "Data", "From", "MET409", "Combination", "Trial", "In", "Diabetes,", "NASH", "Patients"], "created_at": "2021-11-02 15:25:13"}
{"text": ["UPDATE", "2-Lilly", "pulls", "COVID-19", "treatment", "from", "EU", "review", "while", "U.S.", "stocks", "up"], "created_at": "2021-11-02 14:50:20"}
{"text": ["Was", "The", "Smart", "Money", "Right", "About", "Eli", "Lilly", "and", "Company", "(LLY)?"], "created_at": "2021-11-02 14:14:51"}
{"text": ["The", "Daily", "Biotech", "Pulse:", "Pfizer", "Reports", "Solid", "Q3", "Earnings,", "Regulatory", "Setback", "For", "Legend,", "Lilly", "to", "Supply", "Additional", "COVID-19", "Antibody", "Cocktails", "To", "US"], "created_at": "2021-11-02 11:52:52"}
{"text": ["UPDATE", "1-U.S.", "buys", "more", "doses", "of", "Lilly's", "COVID-19", "treatment", "for", "$1.29", "bln"], "created_at": "2021-11-02 11:29:09"}
{"text": ["Lilly", "to", "supply", "614,000", "additional", "doses", "of", "bamlanivimab", "and", "etesevimab", "to", "the", "U.S.", "Government", "for", "the", "treatment", "or", "post-exposure", "prevention", "of", "COVID-19"], "created_at": "2021-11-02 10:45:00"}
